Iqra Ilyas

2.1k total citations · 3 hit papers
16 papers, 1.4k citations indexed

About

Iqra Ilyas is a scholar working on Immunology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Iqra Ilyas has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Epidemiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Iqra Ilyas's work include Atherosclerosis and Cardiovascular Diseases (6 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Lipid metabolism and disorders (3 papers). Iqra Ilyas is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (6 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Lipid metabolism and disorders (3 papers). Iqra Ilyas collaborates with scholars based in China, Australia and United States. Iqra Ilyas's co-authors include Suowen Xu, Jianping Weng, Peter J. Little, Danielle Kamato, Xueying Zheng, Sihui Luo, Jihong Han, Scott J. Cameron, Hong Li and Ian C. Harding and has published in prestigious journals such as Pharmacological Reviews, International Journal of Molecular Sciences and Trends in Pharmacological Sciences.

In The Last Decade

Iqra Ilyas

16 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

2021 686 citations Suowen Xu, Iqra Ilyas et al. Pharmacological Reviews profile →
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

2022 234 citations Suowen Xu, Iqra Ilyas et al. Acta Pharmacologica Sinica profile →
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

2021 188 citations Xiaoxuan Ma, Zhenghong Liu et al. International Journal of Biological Sciences profile →

Peers

Iqra Ilyas

IMMUN

EDM

CCM

SURGE

Vijayakumar Sukumaran Japan

Yuhua Zhang China

Chiara Stranieri Italy

Tlili Barhoumi Saudi Arabia

Tianshu Zeng China

Zhongren Ding China

Angela Tesse France

Angelica Giuliani Italy

Giulia Matacchione Italy

Jayakumar Thangavel United States

Vijayakumar Sukumaran Japan

Iqra Ilyas

736 ×1.5

166 ×0.6

IMMUN

372 ×1.3

EDM

468 ×1.8

CCM

190 ×0.8

SURGE

Citations per year, relative to Iqra Ilyas Iqra Ilyas (= 1×) peers Vijayakumar Sukumaran

Countries citing papers authored by Iqra Ilyas

Since Specialization

Citations

This map shows the geographic impact of Iqra Ilyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iqra Ilyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iqra Ilyas more than expected).

Fields of papers citing papers by Iqra Ilyas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iqra Ilyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iqra Ilyas. The network helps show where Iqra Ilyas may publish in the future.

Co-authorship network of co-authors of Iqra Ilyas

This figure shows the co-authorship network connecting the top 25 collaborators of Iqra Ilyas. A scholar is included among the top collaborators of Iqra Ilyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iqra Ilyas. Iqra Ilyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Yu, Wei, et al.. (2024). The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic review. Journal of Pharmacy and Pharmacology. 77(2). 206–221. 2 indexed citations

Yin, Yanjun, et al.. (2024). Bioactive Flavonoids in Protecting Against Endothelial Dysfunction and Atherosclerosis. Handbook of experimental pharmacology. 287. 1–31. 6 indexed citations

Jiang, Hui, Lu Sun, Meijie Chen, et al.. (2023). A proteome-wide screen identifies the calcium binding proteins, S100A8/S100A9, as clinically relevant therapeutic targets in aortic dissection. Pharmacological Research. 199. 107029–107029. 7 indexed citations

Yu, Wei, et al.. (2022). A review on therapeutical potential of paeonol in atherosclerosis. Frontiers in Pharmacology. 13. 950337–950337. 24 indexed citations

Ilyas, Iqra, Peter J. Little, Zhiping Liu, et al.. (2022). Mouse models of atherosclerosis in translational research. Trends in Pharmacological Sciences. 43(11). 920–939. 57 indexed citations

Xu, Suowen, Qing Lyu, Iqra Ilyas, Xiao Yu Tian, & Jianping Weng. (2022). Vascular homeostasis in atherosclerosis: A holistic overview. Frontiers in Immunology. 13. 976722–976722. 17 indexed citations

Xu, Suowen, Iqra Ilyas, & Jianping Weng. (2022). Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacologica Sinica. 44(4). 695–709. 234 indexed citations breakdown →

Yu, Wei, et al.. (2022). Therapeutic potential of paeoniflorin in atherosclerosis: A cellular action and mechanism-based perspective. Frontiers in Immunology. 13. 1072007–1072007. 17 indexed citations

Kamato, Danielle, Iqra Ilyas, Suowen Xu, & Peter J. Little. (2022). Non-Mouse Models of Atherosclerosis: Approaches to Exploring the Translational Potential of New Therapies. International Journal of Molecular Sciences. 23(21). 12964–12964. 5 indexed citations

10.

Ma, Xiaoxuan, Zhenghong Liu, Iqra Ilyas, et al.. (2021). GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. International Journal of Biological Sciences. 17(8). 2050–2068. 188 indexed citations breakdown →

11.

Xu, Suowen, Yujie Liu, Yu Ding, et al.. (2021). The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduction and Targeted Therapy. 6(1). 266–266. 40 indexed citations

12.

Xu, Suowen, Iqra Ilyas, Peter J. Little, et al.. (2021). Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacological Reviews. 73(3). 924–967. 686 indexed citations breakdown →

13.

Riaz, Muhammad, Sadia Nawaz, Iqra Ilyas, et al.. (2021). Evaluation of antidiabetic, antioxidant, and cytotoxic potential of maize (zea mays l.) husk leaf extracts. Cellular and Molecular Biology. 67(1). 165–170. 4 indexed citations

14.

Liu, Zhenghong, Xiaoxuan Ma, Iqra Ilyas, et al.. (2021). Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics. Theranostics. 11(9). 4502–4515. 110 indexed citations

15.

Rizwan, Hafiz Muhammad, et al.. (2020). CT analysis of subcutaneous and visceral adipose tissue in normal BMI subjects: association with level of physical activity and hypertension. Advancements in Life Sciences. 7(3). 164–169. 1 indexed citations

16.

Ilyas, Iqra, et al.. (2017). Effects of Hibiscus sabdariffa Linn. on Malondialdehyde and Glutathione Peroxidase in an Overtraining Rat Model characterized by Growth Hormone, Insulin-like Growth Factor-1, and Insulin-like Growth Factor Binding Protein-3. Biomedical & Pharmacology Journal. 10(1). 19–27. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact